Back

Transient cardiomyopathy by tyrosine kinase inhibitor therapy: time to define a new syndrome in cardio-oncology?

European Heart Journal

3 December 2025
Organised by: Logo
Read full article
ESC Journals

Contributors

Lorenz H Lehmann
Lorenz H Lehmann

Author

University Hospital Heidelberg Heidelberg , Germany

ESC 365 is supported by

novartis Explore sponsored resources